These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 34797837)
1. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837 [TBL] [Abstract][Full Text] [Related]
2. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis. Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339 [TBL] [Abstract][Full Text] [Related]
3. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC. Guo Q; Qiu P; Yao Q; Chen J; Lin J Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217 [TBL] [Abstract][Full Text] [Related]
4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
5. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549 [TBL] [Abstract][Full Text] [Related]
6. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer. Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032 [TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
9. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining. Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373 [TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961 [TBL] [Abstract][Full Text] [Related]
11. Detection of critical genes associated with poor prognosis in breast cancer via integrated bioinformatics analyses. Liu D; Zhang J; Li L; Wang Q; Lan Y J BUON; 2020; 25(6):2537-2545. PubMed ID: 33455094 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma. Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802 [No Abstract] [Full Text] [Related]
13. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis. Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357 [TBL] [Abstract][Full Text] [Related]
14. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers. Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses. Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220 [TBL] [Abstract][Full Text] [Related]
16. Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma. Cui Z; Song Q; Chen Y; Yang K Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):280-289. PubMed ID: 35132271 [TBL] [Abstract][Full Text] [Related]
17. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis. Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355 [TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis. Deng JL; Xu YH; Wang G Front Genet; 2019; 10():695. PubMed ID: 31428132 [No Abstract] [Full Text] [Related]
19. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056 [TBL] [Abstract][Full Text] [Related]
20. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing. Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]